Report copyright - Therapeutic Class Overview Antiasthmatic Monoclonal Antibodies · Reslizumab (Cinqair®) Severe eosinophilic-phenotype asthma in adults Solution for Injection: 100 mg/10 mL - Evidence-based
Please pass captcha verification before submit form